University of Natal Report issue

Academic/Hospital Phase 1 Phase 3

Organization Overview

First Clinical Trial
2003
NCT00063778
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2007

Timeline

NOW
  • Now

Alternative names

Centre for HIV Networking (HIVAN), Nelson Mandela School of Medicine, University of Natal | Department of Obstetrics and Gynaecology, Nelson R Mandela School of Medicine, University of Natal | University of Natal, Durban, South Africa

Active Ingredients

Drugs in Phase 3 Trials (1)

nevirapine (viramune) (1 trial)

Drugs in Phase 1 Trials (1)

avx101 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

HIV Infections (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 2